FAKTOR YANG BERHUBUNGAN DENGAN IDWG DAN TEKANAN DARAH PASIEN HEMODIALIS DI RUMAH SAKIT SWASTA YOGYAKARTA

2019 ◽  
Vol 7 (3) ◽  
pp. 223-231
Author(s):  
Th Tatik Pujiastuti

Background:  Patients with hemodialysis always increase every year. In Indonesia the number of active hemodialysis in 2016 increased by 72.29% from 2015. The success of hemodialysis can be seen from the clinical condition of the patient, especially Interdialitic Weigh Giant (IDWG) and blood pressure. Therefore, it is very important to study related  factors to IDWG and blood pressure in hemodialysis patients. Objective: This study aims to describe related factors  to IDWG and blood pressure in hemodialysis patients. Methods: This is a quantitative descriptive analytic research. Number of samples is 65 hemodialysis patients using random technique. Result: Based on the Spearman correlation test showed that statistically, there is a correlation between  gender and  IDWG p 0,024 < 0,05, Exercise and Intradialysis diastolic blood pressure with p 0,000 <0,05 (r = 0,46), comorbidities with Intradialysis diastolic blood pressure p 0,000 < 0,05 and fluid intake with intradialysis  systolic blood pressure p 0,031 <0,05 (r = 0.28).  Conclusion: It is assumed that gender, exercise, comorbidities and fluid intake are related to IDWG and blood pressure. Based on result of this study, this is important for nurses to take more intensive education about controlling cimorbidities, fluid intake and motivation to exercise in daily life.   Keywords: Hemodialysis, blood pressure,  Interdialitic Weigh Giant (IDWG)

2019 ◽  
Vol 7 (3) ◽  
pp. 223-231
Author(s):  
Th Tatik Pujiastuti

Background:  Patients with hemodialysis always increase every year. In Indonesia the number of active hemodialysis in 2016 increased by 72.29% from 2015. The success of hemodialysis can be seen from the clinical condition of the patient, especially Interdialitic Weigh Giant (IDWG) and blood pressure. Therefore, it is very important to study related  factors to IDWG and blood pressure in hemodialysis patients. Objective: This study aims to describe related factors  to IDWG and blood pressure in hemodialysis patients. Methods: This is a quantitative descriptive analytic research. Number of samples is 65 hemodialysis patients using random technique. Result: Based on the Spearman correlation test showed that statistically, there is a correlation between  gender and  IDWG p 0,024 < 0,05, Exercise and Intradialysis diastolic blood pressure with p 0,000 <0,05 (r = 0,46), comorbidities with Intradialysis diastolic blood pressure p 0,000 < 0,05 and fluid intake with intradialysis  systolic blood pressure p 0,031 <0,05 (r = 0.28).  Conclusion: It is assumed that gender, exercise, comorbidities and fluid intake are related to IDWG and blood pressure. Based on result of this study, this is important for nurses to take more intensive education about controlling cimorbidities, fluid intake and motivation to exercise in daily life. Keywords: Hemodialysis, blood pressure,  Interdialitic Weigh Giant (IDWG)


Hypertension ◽  
2020 ◽  
Vol 75 (6) ◽  
pp. 1439-1446 ◽  
Author(s):  
Chang Seong Kim ◽  
Kyung-Do Han ◽  
Hong Sang Choi ◽  
Eun Hui Bae ◽  
Seong Kwon Ma ◽  
...  

Data regarding health behavior-related factors and systolic or diastolic blood pressure to evaluate the association between blood pressure and kidney cancer are lacking. Using nationally representative data from the Korean National Health Insurance System, 9 746 445 participants without kidney cancer between January 1, 2006 and December 31, 2009 were followed up until December 31, 2017 to obtain data regarding cancer incidence. Participants were categorized, according to blood pressure, as normal (<120/80 mm Hg), elevated (120–129/<80 mm Hg), and hypertensive (≥130/80 mm Hg) with or without antihypertensive medication, according to the 2017 American College of Cardiology and American Heart Association blood pressure guidelines. Kidney cancer was noted in 11 083 participants during the 8-year follow-up. Participants with hypertension were at higher risk for kidney cancer than those without hypertension. Participants with hypertension using medication had a higher cancer risk than those not using medication and those with elevated blood pressure. The risk of kidney cancer significantly increased with higher systolic or diastolic blood pressure, in a dose-dependent manner, even after adjusting for antihypertensive medication use. Therefore, hypertension and high systolic or diastolic blood pressure, compared with normal blood pressure, were associated with an increased risk of kidney cancer.


1991 ◽  
Vol 2 (4) ◽  
pp. 927-936
Author(s):  
P A Abraham ◽  
M G Macres

This study analyzed blood pressure in hemodialysis patients treated with epoetin beta in multicenter trials. Antihypertensive drugs were prescribed as usual. Placebo-controlled trials compared epoetin (100 to 150 U/kg; N = 151) with placebo (N = 78) for 82 days. Hemoglobin (108 +/- 18 versus 75 +/- 14 g/L) (mean +/- SD) and diastolic blood pressure (84 +/- 14 versus 78 +/- 15 mm Hg) were greater (P less than 0.05) after epoetin. Clinically important increases in blood pressure (increases in diastolic blood pressure greater than or equal to 10 mm Hg and/or drug therapy) were more frequent with epoetin (58 versus 37%; P = 0.005). A dose-response trial compared epoetin, 25 U/kg (N = 42), 100 U/kg (N = 40), and 200 U/kg (N = 39) for 138 days. Increases in hemoglobin were dose dependent, but clinically important increases in blood pressure were not. In analyses of all patients treated with epoetin (N = 272), no baseline or final level of hemoglobin, or rate of hemoglobin rise, was a threshold for a rise in blood pressure. Patients requiring antihypertensive drugs or having uncontrolled hypertension (diastolic blood pressure greater than 90 mm Hg) at baseline had decreases in blood pressure (P less than 0.05) with antihypertensive therapy. Thus, compared with placebo, 21% of patients had clinically important increases in blood pressure during amelioration of anemia. The baseline or final levels of hemoglobin, the extent or rate of hemoglobin rise, or uncontrolled hypertension or antihypertensive drug use at baseline were not confirmed as risks. Antihypertensive drug therapy was important for blood pressure control.


Author(s):  
Deni W. Suryono

Objective: To analyze the differences of calcium serum and calcium urine level in preeclampsia and normal pregnancy, and to analyze the correlation between calcium serum and calcium urine level with blood pressure. Method: This study is a cross sectional study with 44 women with preeclampsia and 45 women with normal pregnancies, that meet our inclusion criteria. The samples were obtained from Dr. Hasan Sadikin Hospital and six satellite hospitals from June to September 2011. The comparison of mean calcium serum and calcium urine level of the preeclampsia group was calculated using Mann-Whitney test, and the correlation between calcium serum and calcium urine level and preeclampsia were calculated using Rank Spearman correlation test. Result: The result of the characteristic test in two groups of study shows that both groups are homogenic and comparable. The mean of calcium serum level in women with preeclampsia (7.97 mg/dl) is lower than in normal pregnancy (8.82 mg/dl) with p


2021 ◽  
Vol 32 (4) ◽  
pp. 459-465
Author(s):  
Rahmiyati Daud ◽  
Bambang Subakti Zulkarnain ◽  
Ivan Virnanda Amu

Abstract Objectives Hypertension is one of the main factors in increasing the risk of cardiovascular disease with 51% reported cause of death in chronic kidney disease (CKD) patients with end-stage renal disease (ESRD). It is a comorbid that needs to be managed properly and gets special attention from various health disciplines including a pharmacist. Methods This was a quasi experimental study with pretest–posttest intervention using home pharmacy care (HPC) counseling both on the counseling and the noncounseling group. Initial data collection and informed consent was done at the Hemodialysis Unit Aloei Saboe and Toto Kabila Hospital, Gorontalo. The parameters in the study were patients’ compliance to their medication using the Medication Adherence Questionnaire (MAQ) and Pill Count Adherence (PCA) questionnaires and the patient’s blood pressure. Results Fifty-eight patients met the inclusion criteria and were divided into two groups (the counseling group and the noncounseling group). Based on MAQ and PCA, the level of patient medication adherence increased significantly in the counseling group compared to the noncounseling group with a significance value of p<0.05. Increasing adherence was correlated with patients’ outcome of lowering blood pressure. More patients in the counseling group showed decrease in systolic and diastolic blood pressure compared to the noncounseling group (86.2 vs. 17.2% for systolic BP and 69 vs. 10.3% for diastolic blood pressure (BP). Following adjusted confounding variables, counseling through HPC provided a chance of decreasing systolic blood pressure 32 times (95% CI: 7.198–144.550) and diastolic blood pressure 42 times (95% CI: 6.204–286.677). Conclusions HPC affects the improvement of patient medication adherence and reduction of blood pressure in hemodialysis patients with hypertension.


1997 ◽  
Vol 51 (4) ◽  
pp. 1212-1217 ◽  
Author(s):  
Kunitoshi Iseki ◽  
Fujihiko Miyasato ◽  
Kiyoyuki Tokuyama ◽  
Keizo Nishime ◽  
Hajime Uehara ◽  
...  

2020 ◽  
Vol 5 (2) ◽  
pp. e21-e21
Author(s):  
Parvin Soltani ◽  
Naser Saeedi ◽  
Navidreza Mashaykhi ◽  
Alireza Rostami ◽  
Maryam Tajfar

Introduction: In spite of widely accepted idea that exercise is beneficial in dialysis, it is not easy to incorporate an exercise program into routine clinical practice of these patients. Objectives: The present study was conducted to evaluate the effects of exercise on hemodialysis patients. Patients and Methods: In this non-pharmacologic clinical trial, a total of 49 clinically stable hemodialysis patients were enrolled in the study and were randomly allocated into two groups; the intervention group (n=27) and the control group (n=22). The intervention group conducted at least 30 minutes of cycling during each hemodialysis session for six months. Intradialytic blood pressure, high-sensitivity C-reactive protein (hs-CRP) blood levels and dialysis adequacy were estimated before and after dialysis. Results: At the end of the 6-month study period, a significant reduction in systolic and diastolic blood pressure in all patients of the intervention group (P<0.05) was detected. Although the dialysis quality increased more than 1.2, it was not statistically significant. Moreover hs-CRP was decreased in the exercise group at the end of the study, while these outcomes were not statistically significant too. Conclusion: Intradialytic exercise can lead to a significant reduction in systolic and diastolic blood pressure in hemodialysis patients. Trial registration: This randomized controlled trial was registered in the Iranian Registry of Clinical Trials (#IRCT2015092324152N1, https://irct.ir/trial/20465, ethical code; ARAKMU.REC.1393.168.1).


2011 ◽  
Vol 55 (7) ◽  
pp. 468-474 ◽  
Author(s):  
Daniela Fedrizzi ◽  
Ticiana Costa Rodrigues ◽  
Fabíola Costenaro ◽  
Rosana Scalco ◽  
Mauro Antônio Czepielewski

INTRODUCTION: There are several complications of the cardiovascular system caused by acromegaly, especially hypertension. OBJECTIVES: To evaluate hypertension characteristics in patients with cured/controlled acromegaly and with the active disease. PATIENTS AND METHODS: Cross-sectional study of the follow-up of forty-four patients with acromegaly submitted to clinical evaluation, laboratory tests and cardiac ultrasound. Patients with cured and controlled disease were evaluated as one group, and individuals with active disease as second one. RESULTS: Forty-seven percent of the patients had active acromegaly, and these patients were younger and had lower blood pressure levels than subjects with controlled/cured disease. Hypertension was detected in 50% of patients. Subjects with active disease showed a positive correlation between IGF-1 and systolic and diastolic blood pressure levels (r = 0.48, p = 0.03; and r = 0.42, p = 0.07, respectively), and a positive correlation between IGF-1 and urinary albumin excretion (UAE) rates. In patients with active disease, IGF-1 was a predictor of systolic blood pressure, although it was not independent of UAE rate. For individuals with cured/controlled disease, waist circumference and triglycerides were the predictors associated with systolic and diastolic blood pressure. CONCLUSIONS: Our findings suggest that blood pressure levels in patients with active acromegaly are very similar, and depend on excess GH. However, once the disease becomes controlled and IGF-1 levels decrease, their blood pressure levels will depend on the other cardiovascular risk factors.


Sign in / Sign up

Export Citation Format

Share Document